ACIP: Influenza Vaccination Recommendations for 2020-2021
Influenza vaccination should occur by the end of October, if possible.
Vaccination
HHS Authorizes Pharmacists to Administer Vaccines to Children
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Underutilization of Influenza Vaccination in Populations at High-Risk for Complications
Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.
Immunization Schedules: Best Available Evidence for 2020
Review of the Advisory Committee Immunization Practices updates to the pediatric immunization schedule and significant revisions to the adult immunization schedule.
Moderna Charging Much More for COVID-19 Vaccine Than Others
Moderna is charging $37 a dose for its experimental vaccine, which is far more than what other companies say they plan to charge for their vaccines.
Vaccine Efficacy Required to Prevent or Extinguish COVID-19 Epidemic
Simulation experiments demonstrated that a vaccine efficacy of 80% is required to extinguish the ongoing COVID-19 pandemic without any other additional measures.
Pfizer, BioNTech Select COVID-19 Vaccine Candidate, Initiate Phase 2/3 Study
Pfizer and BioNTech have selected a coronavirus disease 2019 (COVID-19) vaccine candidate and have initiated their phase 2/3 safety and efficacy trial.
Reduced Hospitalization Among People With Diabetes With Multi-Season Influenza Vaccination
Influenza hospitalizations were decreased among people with diabetes when vaccines were received in multiple influenza seasons.
Early Data Show Investigational ChAdOx1 nCoV-19 Vaccine Safe, Immunogenic
Interim results from the phase 1/2 COV001 trial evaluating the vaccine candidate ChAdOx1 nCoV-19 (AZD1222) showed that vaccination led to strong immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in all evaluated participants.
2008 to 2018 Saw Increase in Shingles Vaccination in Over 60s
From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years and older, with demographic, socioeconomic, and geographic variations in vaccination rates.
-
Loading...
-
Loading...
Next post in Prevention
